George Ertl

Q: What Schools Are Affiliated With George Ertl

George Ertl is affiliated with the following schools: Saarland University, University of Milan, Hannover Medical School, University of Würzburg, Pompeu Fabra University

George Ertl's AcademicInfluence.com Rankings

George Ertl

Philosophy

#5878

World Rank

#8802

Historical Rank

Logic

#3086

World Rank

#4194

Historical Rank

philosophy Degrees

Download Badge

Philosophy

George Ertl's Degrees

PhD Biomedical Sciences University of California, San Francisco
Doctorate Medicine Stanford University

Why Is George Ertl Influential?

(Suggest an Edit or Addition)

(See a Problem?)

George Ertl's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease (2017) (1499)
MicroRNAs in the Human Heart: A Clue to Fetal Gene Reprogramming in Heart Failure (2007) (954)
Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency† (2014) (837)
Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. (2005) (773)
Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. (1997) (724)
Impact of Myocardial Fibrosis in Patients With Symptomatic Severe Aortic Stenosis (2009) (654)
Foxp3+ CD4+ T Cells Improve Healing After Myocardial Infarction by Modulating Monocyte/Macrophage Differentiation (2014) (454)
Long-Term Effects of Enzyme Replacement Therapy on Fabry Cardiomyopathy: Evidence for a Better Outcome With Early Treatment (2009) (429)
MicroRNA-24 Regulates Vascularity After Myocardial Infarction (2011) (394)
Improvement of Cardiac Function During Enzyme Replacement Therapy in Patients With Fabry Disease: A Prospective Strain Rate Imaging Study (2003) (390)
Endothelial Nitric Oxide Synthase Uncoupling Impairs Endothelial Progenitor Cell Mobilization and Function in Diabetes (2007) (385)
31P Magnetic Resonance Spectroscopy in Dilated Cardiomyopathy and Coronary Artery Disease: Altered Cardiac High‐Energy Phosphate Metabolism in Heart Failure (1992) (383)
Endothelial dysfunction in chronic myocardial infarction despite increased vascular endothelial nitric oxide synthase and soluble guanylate cyclase expression: role of enhanced vascular superoxide production. (1999) (369)
Activation of CD4+ T Lymphocytes Improves Wound Healing and Survival After Experimental Myocardial Infarction in Mice (2012) (360)
Direct evidence for a β1-adrenergic receptor–directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy (2004) (323)
Limitation of Experimental Infarct Size by an Angiotensin‐converting Enzyme Inhibitor (1982) (322)
Mechanisms of Disease: Toll-like receptors in cardiovascular disease (2007) (309)
Healing after myocardial infarction. (2005) (307)
Post-infarct remodelling: contribution of wound healing and inflammation (2008) (290)
Age-Dependent Impairment of Endothelial Progenitor Cells Is Corrected by Growth Hormone Mediated Increase of Insulin-Like Growth Factor-1 (2007) (290)
Complementary and Incremental Mortality Risk Prediction by Cortisol and Aldosterone in Chronic Heart Failure (2007) (280)
Low-gradient aortic valve stenosis myocardial fibrosis and its influence on function and outcome. (2011) (276)
Improvement of Left Ventricular Remodeling and Function by Hydroxymethylglutaryl Coenzyme A Reductase Inhibition With Cerivastatin in Rats With Heart Failure After Myocardial Infarction (2001) (261)
Safety of Proton Pump Inhibitors Based on a Large, Multi-year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin. (2019) (249)
Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine. (2005) (245)
The variation of morphological and functional cardiac manifestation in Fabry disease: potential implications for the time course of the disease. (2005) (232)
Effect of Escitalopram on All-Cause Mortality and Hospitalization in Patients With Heart Failure and Depression: The MOOD-HF Randomized Clinical Trial. (2016) (217)
Cannabinoids Acting on CB1 Receptors Decrease Contractile Performance in Human Atrial Muscle (2003) (212)
Mode of Action and Effects of Standardized Collaborative Disease Management on Mortality and Morbidity in Patients With Systolic Heart Failure: The Interdisciplinary Network for Heart Failure (INH) Study (2012) (203)
Deletion of Cardiomyocyte Mineralocorticoid Receptor Ameliorates Adverse Remodeling After Myocardial Infarction (2011) (203)
Short Communication: Asymmetric Dimethylarginine Impairs Angiogenic Progenitor Cell Function in Patients With Coronary Artery Disease Through a MicroRNA-21–Dependent Mechanism (2010) (185)
Transforming growth factor beta inhibition increases mortality and left ventricular dilatation after myocardial infarction (2008) (183)
Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. (2004) (182)
Long-term outcome of enzyme-replacement therapy in advanced Fabry disease: evidence for disease progression towards serious complications (2013) (178)
Heart failure: the commonest reason for hospital admission in Germany: medical and economic perspectives. (2009) (174)
Additive improvement of left ventricular remodeling and neurohormonal activation by aldosterone receptor blockade with eplerenone and ACE inhibition in rats with myocardial infarction. (2003) (172)
Chronic endothelin receptor blockade attenuates progressive ventricular dilation and improves cardiac function in rats with myocardial infarction: possible involvement of myocardial endothelin system in ventricular remodeling. (1997) (163)
Addition of spironolactone to angiotensin-converting enzyme inhibition in heart failure improves endothelial vasomotor dysfunction: role of vascular superoxide anion formation and endothelial nitric oxide synthase expression. (2002) (158)
Sustained activation of nuclear factor kappa B and activator protein 1 in chronic heart failure. (2003) (156)
"GOLD or lower limit of normal definition? a comparison with expert-based diagnosis of chronic obstructive pulmonary disease in a prospective cohort-study" (2012) (156)
Endogenous cannabinoids mediate hypotension after experimental myocardial infarction. (2001) (155)
Differences in Fabry cardiomyopathy between female and male patients: consequences for diagnostic assessment. (2011) (155)
An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registry. (2004) (154)
Monocytes/macrophages prevent healing defects and left ventricular thrombus formation after myocardial infarction (2013) (154)
Factor XIII Deficiency Causes Cardiac Rupture, Impairs Wound Healing, and Aggravates Cardiac Remodeling in Mice With Myocardial Infarction (2006) (149)
Downregulation of the Na(+)-creatine cotransporter in failing human myocardium and in experimental heart failure. (1999) (145)
Clinical implication of mitral annular plane systolic excursion for patients with cardiovascular disease. (2013) (143)
Increased Mortality and Aggravation of Heart Failure in Estrogen Receptor-&bgr; Knockout Mice After Myocardial Infarction (2005) (141)
Previously known and newly diagnosed atrial fibrillation: A major risk indicator after a myocardial infarction complicated by heart failure or left ventricular dysfunction ☆ (2006) (140)
Effect of Combined Systolic and Diastolic Functional Parameter Assessment for Differentiation of Cardiac Amyloidosis From Other Causes of Concentric Left Ventricular Hypertrophy (2013) (140)
Novel role of the membrane-bound chemokine fractalkine in platelet activation and adhesion. (2004) (139)
Immediate Mineralocorticoid Receptor Blockade Improves Myocardial Infarct Healing by Modulation of the Inflammatory Response (2008) (135)
Attenuation of Angiotensin II–Induced Vascular Dysfunction and Hypertension by Overexpression of Thioredoxin 2 (2009) (134)
Rationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) Trial. (2017) (133)
Mechanisms underlying recoupling of eNOS by HMG-CoA reductase inhibition in a rat model of streptozotocin-induced diabetes mellitus. (2008) (128)
A genome-wide association study identifies 6p21 as novel risk locus for dilated cardiomyopathy. (2014) (126)
Gene Mutations Versus Clinically Relevant Phenotypes: Lyso-Gb3 Defines Fabry Disease (2014) (124)
Absence of NF‐κB subunit p50 improves heart failure after myocardial infarction (2006) (124)
Two-dimensional speckle tracking as a non-invasive tool for identification of myocardial fibrosis in Fabry disease. (2013) (123)
Role of endothelial nitric oxide synthase in endothelial activation: insights from eNOS knockout endothelial cells. (2004) (123)
Randomized trial of candesartan cilexetil in the treatment of patients with congestive heart failure and a history of intolerance to angiotensin-converting enzyme inhibitors. (2000) (121)
Bone marrow molecular alterations after myocardial infarction: Impact on endothelial progenitor cells. (2006) (121)
Effect of additional temporary glycoprotein IIb/IIIa receptor inhibition on troponin release in elective percutaneous coronary interventions after pretreatment with aspirin and clopidogrel (TOPSTAR trial). (2002) (118)
Overexpression of the sarcolemmal calcium pump in the myocardium of transgenic rats. (1998) (118)
Relation of burden of myocardial fibrosis to malignant ventricular arrhythmias and outcomes in Fabry disease. (2014) (114)
Improvement in Left Ventricular Remodeling by the Endothelial Nitric Oxide Synthase Enhancer AVE9488 After Experimental Myocardial Infarction (2008) (113)
Susceptibility-sensitive magnetic resonance imaging detects human myocardium supplied by a stenotic coronary artery without a contrast agent. (2003) (111)
Effect of endurance training early or late after coronary artery occlusion on left ventricular remodeling, hemodynamics, and survival in rats with chronic transmural myocardial infarction. (1994) (111)
Depression and disease severity as predictors of health-related quality of life in patients with chronic heart failure--a structural equation modeling approach. (2009) (110)
Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry. (1999) (109)
Downregulation of the Na+-creatine cotransporter in experimental and in human heart failure (1999) (109)
Pulmonary artery pressure‐guided therapy in ambulatory patients with symptomatic heart failure: the CardioMEMS European Monitoring Study for Heart Failure (MEMS‐HF) (2020) (101)
Contributions of 31P-magnetic resonance spectroscopy to the understanding of dilated heart muscle disease. (1995) (100)
A new echocardiographic approach for the detection of non-ischaemic fibrosis in hypertrophic myocardium. (2007) (100)
Time course of cardiac structural, functional and electrical changes in asymptomatic patients after myocardial infarction: their inter-relation and prognostic impact. (2001) (99)
Reverse Epidemiology in Systolic and Nonsystolic Heart Failure: Cumulative Prognostic Benefit of Classical Cardiovascular Risk Factors (2009) (96)
Depression and survival in chronic heart failure: Does gender play a role? (2007) (95)
Rationale and design of a randomised, controlled, multicenter trial investigating the effects of selective serotonin re‐uptake inhibition on morbidity, mortality and mood in depressed heart failure patients (MOOD‐HF) (2007) (94)
Magnetic resonance imaging safety in pacemaker and implantable cardioverter defibrillator patients: how far have we come? (2015) (91)
A novel fluorescence method for the rapid detection of functional beta1-adrenergic receptor autoantibodies in heart failure. (2007) (90)
Nurse‐coordinated collaborative disease management improves the quality of guideline‐recommended heart failure therapy, patient‐reported outcomes, and left ventricular remodelling (2015) (87)
eNOS Protects from Atherosclerosis Despite Relevant Superoxide Production by the Enzyme in apoE−/− Mice (2012) (85)
Protective effects of sphingosine-1-phosphate receptor agonist treatment after myocardial ischaemia-reperfusion. (2009) (84)
Sex Differences in Percutaneous Coronary Intervention—Insights From the Coronary Angiography and PCI Registry of the German Society of Cardiology (2017) (84)
Imaging of myocardial inflammation with somatostatin receptor based PET/CT - A comparison to cardiac MRI. (2015) (83)
Serial cine‐magnetic resonance imaging of left ventricular remodeling after myocardial infarction in rats (2001) (83)
The estrogen receptor-alpha agonist 16alpha-LE2 inhibits cardiac hypertrophy and improves hemodynamic function in estrogen-deficient spontaneously hypertensive rats. (2005) (83)
Mineralocorticoid Receptor Blockade Improves Vasomotor Dysfunction and Vascular Oxidative Stress Early After Myocardial Infarction (2007) (82)
Airway obstruction in systolic heart failure--COPD or congestion? (2013) (82)
Cardiac magnetic resonance imaging in small animal models of human heart failure (2003) (82)
Epidemiology of Chagas disease in Europe: many calculations, little knowledge (2013) (81)
Absence of NF-kappaB subunit p50 improves heart failure after myocardial infarction. (2006) (81)
Chronic effects of early started angiotensin converting enzyme inhibition and angiotensin AT1-receptor subtype blockade in rats with myocardial infarction: role of bradykinin. (1998) (80)
Pantoprazole to Prevents Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-blind, Placebo-controlled Trial. (2019) (79)
Effects of Endothelin-1 in Isolated Perfused Rat Heart (1990) (78)
Effect of testosterone on post-myocardial infarction remodeling and function. (2003) (76)
Ligand-dependent activation of ER{beta} lowers blood pressure and attenuates cardiac hypertrophy in ovariectomized spontaneously hypertensive rats. (2008) (75)
Collagen accumulation after myocardial infarction: effects of ETA receptor blockade and implications for early remodeling. (2002) (75)
Creatine kinase knockout mice show left ventricular hypertrophy and dilatation, but unaltered remodeling post-myocardial infarction. (2005) (74)
Relation of circulating markers of fibrosis and progression of left and right ventricular dysfunction in hypertensive patients with heart failure (2009) (74)
Repetitive postprandial hyperglycemia increases cardiac ischemia/reperfusion injury: prevention by the α‐glucosidase inhibitor acarbose (2005) (73)
Tissue inhibitor of metalloproteinases levels in patients with chronic heart failure: An independent predictor of mortality (2008) (71)
Cardiac β1‐adrenoceptor autoantibodies in human heart disease: rationale and design of the Etiology, Titre‐Course, and Survival (ETiCS) Study (2010) (71)
Fabry disease and the heart. (2015) (70)
Incidence rates and predictors of major and minor depression in patients with heart failure. (2013) (70)
Peroxisome proliferator activated‐receptor agonism and left ventricular remodeling in mice with chronic myocardial infarction (2004) (70)
Fast High-Resolution Magnetic Resonance Imaging Demonstrates Fractality of Myocardial Perfusion in Microscopic Dimensions (2001) (70)
Cardiac high-energy phosphate metabolism in patients with aortic valve disease assessed by 31P-magnetic resonance spectroscopy. (1997) (69)
Tumor Necrosis Factor- α at Acute Myocardial Infarction in Rats andÈEffects on Cardiac Fibroblasts☆ (1999) (68)
Cyclooxygenase-2 in myocardium stimulation by angiotensin-II in cultured cardiac fibroblasts and role at acute myocardial infarction. (2002) (68)
Pharmacotherapy according to treatment guidelines is associated with lower mortality in a community‐based sample of patients with chronic heart failure A prospective cohort study (2008) (68)
Improvement of vascular function by acute and chronic treatment with the PDE‐5 inhibitor sildenafil in experimental diabetes mellitus (2008) (67)
Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort study. (2020) (67)
Tissue-specific effects of the nuclear factor kappaB subunit p50 on myocardial ischemia-reperfusion injury. (2007) (67)
The right ventricle in Fabry disease: natural history and impact of enzyme replacement therapy (2010) (67)
Addition of the selective aldosterone receptor antagonist eplerenone to ACE inhibition in heart failure: effect on endothelial dysfunction. (2003) (66)
Is health-related quality of life an independent predictor of survival in patients with chronic heart failure? (2007) (65)
Atheroprotective Effects of Neuronal Nitric Oxide Synthase in Apolipoprotein E Knockout Mice (2006) (65)
Experimental heart failure in rats: effects on cardiovascular circadian rhythms and on myocardial beta-adrenergic signaling. (2000) (64)
Somatic correlates of comorbid major depression in patients with systolic heart failure. (2011) (64)
Rosuvastatin Reduces Platelet Activation in Heart Failure: Role of NO Bioavailability (2005) (64)
Low circulating androgens and mortality risk in heart failure (2009) (63)
Imaging systemic inflammatory networks in ischemic heart disease. (2015) (63)
Additive amelioration of left ventricular remodeling and molecular alterations by combined aldosterone and angiotensin receptor blockade after myocardial infarction. (2005) (61)
Compensatory and noncompensatory left ventricular dilatation after myocardial infarction: time course and hemodynamic consequences at rest and during exercise. (1992) (60)
Reverse Epidemiology in Systolic and Nonsystolic Heart FailureCLINICAL PERSPECTIVE (2009) (60)
CB1 cannabinoid receptor antagonism promotes remodeling and cannabinoid treatment prevents endothelial dysfunction and hypotension in rats with myocardial infarction (2003) (59)
Impairment of endothelial progenitor cell function and vascularization capacity by aldosterone in mice and humans (2010) (59)
The cannabinoid receptor‐1 antagonist rimonabant inhibits platelet activation and reduces pro‐inflammatory chemokines and leukocytes in Zucker rats (2008) (59)
In-hospital outcome of transcatheter vs. surgical aortic valve replacement in patients with aortic valve stenosis: complete dataset of patients treated in 2013 in Germany (2016) (58)
High‐Sensitivity Troponin: A Clinical Blood Biomarker for Staging Cardiomyopathy in Fabry Disease (2016) (58)
Multimodal functional cardiac MRI in creatine kinase-deficient mice reveals subtle abnormalities in myocardial perfusion and mechanics. (2006) (58)
Distribution and function of sodium channel subtypes in human atrial myocardium. (2013) (58)
Generic and disease-specific health-related quality of life in patients with chronic systolic heart failure: impact of depression (2013) (58)
Pathological autoantibodies in cardiomyopathy (2008) (58)
Prognostic impact of subclinical thyroid dysfunction in heart failure. (2013) (57)
Oxidative stress and compartment of gene expression determine proatherosclerotic effects of inducible nitric oxide synthase. (2009) (57)
Cognitive Deficits and Related Brain Lesions in Patients With Chronic Heart Failure. (2018) (57)
Activation of CD 4 T Lymphocytes Improves Wound Healing and Survival After Experimental Myocardial Infarction in Mice (2012) (56)
Striking Increase of Natriuresis by Low-Dose Spironolactone in Congestive Heart Failure Only in Combination With ACE Inhibition: Mechanistic Evidence to Support RALES (2000) (56)
Endothelin-1 contributes to ischemia/reperfusion injury in isolated rat heart-attenuation of ischemic injury by the endothelin-1 antagonists BQ123 and BQ610. (1995) (55)
Left ventricular remodeling after myocardial infarction in mice with targeted deletion of the NADPH oxidase subunit gp91PHOX (2006) (55)
Interleukin-13 Deficiency Aggravates Healing and Remodeling in Male Mice After Experimental Myocardial Infarction (2014) (54)
Prominent papillary muscles in Fabry disease: a diagnostic marker? (2011) (54)
Lyso-Gb3 Indicates that the Alpha-Galactosidase A Mutation D313Y is not Clinically Relevant for Fabry Disease. (2013) (53)
Ventricular remodeling after myocardial infarction. Experimental and clinical studies. (1993) (53)
NCAM(CD56) and RUNX1(AML1) are up-regulated in human ischemic cardiomyopathy and a rat model of chronic cardiac ischemia. (2003) (52)
Dysnatraemia in heart failure (2012) (52)
Impact of hydroxymethylglutaryl coenzyme a reductase inhibition on left ventricular remodeling after myocardial infarction: an experimental serial cardiac magnetic resonance imaging study. (2002) (52)
Cardiac RKIP induces a beneficial β-adrenoceptor–dependent positive inotropy (2015) (52)
2-Arachidonylglycerol Acting on CB1 Cannabinoid Receptors Mediates Delayed Cardioprotection Induced by Nitric Oxide in Rat Isolated Hearts (2006) (52)
Vascular endothelial dysfunction and superoxide anion production in heart failure are p38 MAP kinase-dependent. (2004) (51)
Serial Magnetic Resonance Imaging of Microvascular Remodeling in the Infarcted Rat Heart (2001) (51)
Echocardiographic evaluation of systolic and diastolic function in patients with cardiac amyloidosis. (2011) (50)
[(68)Ga]Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression After Myocardial Infarction. (2015) (49)
Effects of endothelin-1 in the isolated heart in ischemia/reperfusion and hypoxia/reoxygenation injury. (1991) (48)
Assessment of the contractile reserve in patients with intermediate coronary lesions: a strain rate imaging study validated by invasive myocardial fractional flow reserve. (2006) (48)
International REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure (REPORT‐HF): rationale for and design of a global registry (2015) (47)
Cardioprotection by long-term ET(A) receptor blockade and ACE inhibition in rats with congestive heart failure: mono- versus combination therapy. (2002) (47)
Specific detection of CD56 (NCAM) isoforms for the identification of aggressive malignant neoplasms with progressive development. (2009) (47)
The impact of heart failure on the classification of COPD severity. (2012) (47)
Novel desmoplakin mutation: juvenile biventricular cardiomyopathy with left ventricular non-compaction and acantholytic palmoplantar keratoderma (2011) (46)
Nocardial endocarditis of an aortic valve prosthesis. (1987) (46)
Usefulness of an Implantable Loop Recorder to Detect Clinically Relevant Arrhythmias in Patients With Advanced Fabry Cardiomyopathy. (2016) (46)
Impact of depression on quality of life assessment in heart failure. (2010) (46)
Experimental heart failure causes depression-like behavior together with differential regulation of inflammatory and structural genes in the brain (2014) (45)
Quantitative assessment of myocardial perfusion with a spin‐labeling technique: Preliminary results in patients with coronary artery disease (2003) (45)
Impact of imaging landmark on the risk of MRI‐related heating near implanted medical devices like cardiac pacemaker leads (2011) (45)
Heart valve involvement in Fabry cardiomyopathy. (2009) (45)
Early remodelling of the left ventricle in patients with myocardial infarction. (1990) (45)
HMG CoA reductase inhibition and left ventricular mass in hypertrophic cardiomyopathy: a randomized placebo‐controlled pilot study (2007) (45)
Prevention of endothelial dysfunction in heart failure by vitamin E: attenuation of vascular superoxide anion formation and increase in soluble guanylyl cyclase expression. (2001) (45)
The eNOS enhancer AVE 9488: a novel cardioprotectant against ischemia reperfusion injury (2009) (45)
Rationale and design of the CONFIRM‐HF study: a double‐blind, randomized, placebo‐controlled study to assess the effects of intravenous ferric carboxymaltose on functional capacity in patients with chronic heart failure and iron deficiency (2014) (45)
Long-term beta-blocker treatment prevents chronic creatine kinase and lactate dehydrogenase system changes in rat hearts after myocardial infarction. (1996) (44)
Echocardiographic quantification of regional deformation helps to distinguish isolated left ventricular non‐compaction from dilated cardiomyopathy (2012) (44)
Organ manifestations and long-term outcome of Fabry disease in patients with the GLA haplotype D313Y (2016) (44)
Caught in the act: in vivo molecular imaging of the transcription factor NF-kappaB after myocardial infarction. (2006) (44)
A network against failing hearts--introducing the German "Competence Network Heart Failure". (2010) (43)
Aggravation of left ventricular remodeling by a novel specific endothelin ET(A) antagonist EMD94246 in rats with experimental myocardial infarction. (1998) (43)
Differential Effects of Organic Nitrates on Endothelial Progenitor Cells Are Determined by Oxidative Stress (2007) (43)
Endothelin-receptor blockade improves endothelial vasomotor dysfunction in heart failure. (2000) (43)
Long-term effects of beta-adrenergic blocking agent treatment on hemodynamic function and left ventricular remodeling in rats with experimental myocardial infarction: importance of timing of treatment and infarct size. (1998) (43)
Angiotension converting enzyme inhibitors and ischaemic heart disease (1988) (43)
Tumor necrosis factor-alpha at acute myocardial infarction in rats and effects on cardiac fibroblasts. (1999) (43)
Depression, Anxiety, and Cognitive Impairment (2018) (43)
Cardiomyopathy of Friedreich Ataxia (2013) (42)
Cytokine response after percutaneous coronary intervention in stable angina: effect of selective glycoprotein IIb/IIIa receptor antagonism. (2003) (41)
Imaging of C-X-C Motif Chemokine Receptor CXCR4 Expression After Myocardial Infarction With [68Ga]Pentixafor-PET/CT in Correlation With Cardiac MRI. (2018) (41)
Endothelial dysfunction in congestive heart failure: ACE inhibition vs. angiotensin II antagonism (2004) (41)
Sequential changes of myocardial function during acute myocardial infarction, in the early and chronic phase after coronary intervention described by ultrasonic strain rate imaging. (2006) (40)
Longitudinal strain bull’s eye plot patterns in patients with cardiomyopathy and concentric left ventricular hypertrophy (2016) (39)
The different faces of echocardiographic left ventricular hypertrophy: clues to the etiology. (2010) (39)
Transgenic myocardial overexpression of prokineticin receptor-2 (GPR73b) induces hypertrophy and capillary vessel leakage. (2009) (39)
Feasibility of Contrast-Enhanced and Nonenhanced MRI for Intraprocedural and Postprocedural Lesion Visualization in Interventional Electrophysiology: Animal Studies and Early Delineation of Isthmus Ablation Lesions in Patients With Typical Atrial Flutter (2011) (39)
Role of 5-lipoxygenase in myocardial ischemia-reperfusion injury in mice. (2007) (39)
Fibroblast migration after myocardial infarction is regulated by transient SPARC expression (2006) (38)
Determination of regional blood volume and intra‐extracapillary water exchange in human myocardium using Feruglose: First clinical results in patients with coronary artery disease (2002) (38)
Toll-like receptor signaling in the ischemic heart. (2008) (38)
Comparative Potential of the 2-Item Versus the 9-Item Patient Health Questionnaire to Predict Death or Rehospitalization in Heart Failure (2015) (38)
Acute DNase1 treatment improves left ventricular remodeling after myocardial infarction by disruption of free chromatin (2015) (38)
Effects of ACE inhibition and β-receptor blockade on energy metabolism in rats postmyocardial infarction. (1999) (38)
Ezetimibe potently reduces vascular inflammation and arteriosclerosis in eNOS-deficient ApoE ko mice. (2009) (38)
High-dose 17β–estradiol treatment prevents development of heart failure post–myocardial infarction in the rat (2006) (38)
Time course of right ventricular remodeling in rats with experimental myocardial infarction. (2003) (37)
Postpericardiotomy Syndrome and Cardiac Tamponade as a Late Complication After Pacemaker Implantation (2001) (37)
Aging Reduces the Efficacy of Estrogen Substitution to Attenuate Cardiac Hypertrophy in Female Spontaneously Hypertensive Rats (2006) (36)
Methods for assessment of left ventricular systolic function in technically difficult patients with poor imaging quality. (2013) (36)
The CX3C Chemokine Fractalkine Induces Vascular Dysfunction by Generation of Superoxide Anions (2007) (36)
Cytochrome P450 2C expression and EDHF-mediated relaxation in porcine coronary arteries is increased by cortisol. (2002) (36)
The Fabry cardiomyopathy: models for the cardiologist. (2011) (35)
The cardiomyopathy in Friedreich's ataxia - New biomarker for staging cardiac involvement. (2015) (35)
Urinary asymmetric dimethylarginine (ADMA) is a predictor of mortality risk in patients with coronary artery disease. (2012) (35)
Global Differences in Characteristics, Precipitants, and Initial Management of Patients Presenting With Acute Heart Failure. (2020) (35)
Coronary Vasoconstriction in Experimental Myocardial Ischemia (1987) (35)
Safety and feasibility of pulmonary artery pressure-guided heart failure therapy: rationale and design of the prospective CardioMEMS Monitoring Study for Heart Failure (MEMS-HF) (2018) (35)
The proinflammatory cytokines TNF-α and IL-1β impair economy of contraction in human myocardium (2007) (34)
Anaemia and the heart (2005) (34)
Regional biochemical remodeling in non-infarcted tissue of rat heart post-myocardial infarction. (1996) (34)
Differential effects of organic nitrates on endothelial progenitor cells are determined by oxidative stress. (2007) (33)
CB(1) cannabinoid receptor antagonism promotes remodeling and cannabinoid treatment prevents endothelial dysfunction and hypotension in rats with myocardial infarction. (2003) (33)
ADP-induced platelet aggregation frequently fails to detect impaired clopidogrel-responsiveness in patients with coronary artery disease compared to a P2Y12-specific assay (2008) (33)
Pharmacological pre‐ and post‐conditioning with the sphingosine‐1‐phosphate receptor modulator FTY720 after myocardial ischaemia–reperfusion (2010) (33)
Three‐dimensional 31P magnetic resonance spectroscopic imaging of regional high‐energy phosphate metabolism in injured rat heart (1998) (33)
[Drug-eluting coronary stents and drug eluting balloon catheters: summary of the position papers of the DGK]. (2008) (33)
Predictive Value of Assessing Diastolic Strain Rate on Survival in Cardiac Amyloidosis Patients with Preserved Ejection Fraction (2014) (32)
Eplerenone improves vascular function and reduces platelet activation in diabetic rats. (2010) (32)
The septal bulge--an early echocardiographic sign in hypertensive heart disease. (2016) (32)
Reducing RF‐related heating of cardiac pacemaker leads in MRI: Implementation and experimental verification of practical design changes (2012) (32)
Implementation of pharmacotherapy guidelines in heart failure: experience from the German Competence Network Heart Failure (2012) (32)
How to distinguish between ischemic and nonischemic postsystolic thickening: a strain rate imaging study. (2006) (32)
Effect of contrast application on interpretability and diagnostic value of dobutamine stress echocardiography in patients with intermediate coronary lesions: comparison with myocardial fractional flow reserve. (2008) (31)
Anti‐Ischemic Potential of Drugs related to the Renin‐Angiotensin System (2001) (31)
5-Lipoxygenase facilitates healing after myocardial infarction (2013) (30)
Alpha-receptor restriction of coronary blood flow during atrial fibrillation. (1983) (30)
Heparin inhibits bovine testicular hyaluronidase activity in myocardium of dogs with coronary artery occlusion. (1984) (30)
Chronic high-dose creatine feeding does not attenuate left ventricular remodeling in rat hearts post-myocardial infarction. (1999) (29)
Tei index in fabry disease. (2011) (28)
Hydralazine prevents endothelial dysfunction, but not the increase in superoxide production in nitric oxide-deficient hypertension. (1998) (28)
Role of Global Longitudinal Strain in the Prediction of Outcome in Patients With Severe Aortic Valve Stenosis. (2017) (28)
Cognition matters in cardiovascular disease and heart failure. (2012) (28)
Serial changes in left ventricular size after acute myocardial infarction. (1991) (27)
Left Ventricular Geometry and Blood Pressure as Predictors of Adverse Progression of Fabry Cardiomyopathy (2015) (27)
Prognostic potential of midregional pro‐adrenomedullin following decompensation for systolic heart failure: comparison with cardiac natriuretic peptides (2017) (27)
Chronic coronary artery stenosis induces impaired function of remote myocardium: MRI and spectroscopy study in rat. (2003) (27)
Medroxyprogesterone Acetate But Not Drospirenone Ablates the Protective Function of 17β-Estradiol in Aldosterone Salt-Treated Rats (2006) (27)
Hospital preparedness for mass critical care during SARS-CoV-2 pandemic (2020) (27)
Myocardial Fibrosis Predicts 10-Year Survival in Patients Undergoing Aortic Valve Replacement (2018) (27)
Efficacy and safety of serelaxin when added to standard of care in patients with acute heart failure: results from a PROBE study, RELAX‐AHF‐EU (2019) (27)
Cross-sectional baseline analysis of electrocardiography in a large cohort of patients with untreated Fabry disease (2013) (27)
&agr;-Galactosidase A Genotype N215S Induces a Specific Cardiac Variant of Fabry Disease (2017) (26)
Changes of creatine kinase gene expression in rat heart post-myocardial infarction. (1998) (26)
Myocardial perfusion imaging using a non-contrast agent MR imaging technique (2001) (26)
Complement C3c as a Biomarker in Heart Failure (2013) (25)
Myocardial function in patients with multiple sclerosis treated with low-dose mitoxantrone. (2002) (25)
Increased platelet activation in young Zucker rats with impaired glucose tolerance is improved by acarbose (2004) (24)
Value of tissue Doppler-derived Tei index and two-dimensional speckle tracking imaging derived longitudinal strain on predicting outcome of patients with light-chain cardiac amyloidosis (2017) (24)
[Natriuretic peptides--new diagnostic markers in heart disease]. (2004) (24)
Differences in natural history of low- and high-gradient aortic stenosis from nonsevere to severe stage of the disease. (2015) (24)
Novel Receptor-Derived Cyclopeptides to Treat Heart Failure Caused by Anti-β1-Adrenoceptor Antibodies in a Human-Analogous Rat Model (2015) (24)
Functional and energetic consequences of chronic myocardial creatine depletion by beta-guanidinopropionate in perfused hearts and in intact rats. (1999) (24)
Protective effect of the specific endothelin-1 antagonist BQ610 on mechanical function and energy metabolism during ischemia/reperfusion injury in isolated perfused rat hearts. (1996) (24)
Impact of Regional Left Ventricular Function on Outcome for Patients with AL Amyloidosis (2013) (24)
Thrombus Aspiration for ST-Segment–Elevation Myocardial Infarction in Modern Era: Still an Issue of Debate? (2017) (23)
Toll-like receptors as potential therapeutic targets in cardiac dysfunction (2011) (23)
Preservation of left ventricular mechanical function and energy metabolism in rats after myocardial infarction by the angiotensin-converting enzyme inhibitor quinapril. (1996) (23)
Myocardial T1: quantification by using an ECG-triggered radial single-shot inversion-recovery MR imaging sequence. (2015) (23)
Wound model of myocardial infarction. (2005) (23)
Alterations of performance and oxygen utilization in chronically infarcted rat hearts. (1996) (22)
Reverse epidemiology in different stages of heart failure. (2015) (22)
Effect of experimentally induced atrial fibrillation on coronary circulation in dogs (1983) (22)
Effects of structured heart failure disease management on mortality and morbidity depend on patients' mood: results from the Interdisciplinary Network for Heart Failure Study (2014) (22)
Differentiation Between Fresh and Old Left Ventricular Thrombi by Deformation Imaging (2012) (22)
Soluble Guanylyl Cyclase Activation With HMR1766 Attenuates Platelet Activation in Diabetic Rats (2006) (22)
Telmisartan improves vascular function and reduces platelet activation in rats with streptozotocin-induced diabetes mellitus. (2007) (22)
Cardiac metabolism and function in patients with multiple sclerosis: a combined 31P-MR-spectroscopy and MRI study. (2001) (22)
BOLD-MRI in ten patients with coronary artery disease: evidence for imaging of capillary recruitment in myocardium supplied by the stenotic artery. (1999) (22)
Pioglitazone reverses down-regulation of cardiac PPARgamma expression in Zucker diabetic fatty rats. (2005) (22)
Angiotensin II type1 receptor regulation and differential trophic effects on rat cardiac myofibroblasts after acute myocardial infarction (2001) (22)
Expression of neuronal nitric oxide synthase splice variants in atherosclerotic plaques of apoE knockout mice. (2009) (22)
Impact of monitoring longitudinal systolic strain changes during serial echocardiography on outcome in patients with AL amyloidosis (2015) (21)
Functional and metabolic recovery of the right ventricle during Bosentan therapy in idiopathic pulmonary arterial hypertension. (2005) (21)
Improved endothelial function and reduced platelet activation by chronic HMG-CoA-reductase inhibition with rosuvastatin in rats with streptozotocin-induced diabetes mellitus. (2007) (21)
Left ventricular assessment in myocardial infarction: the VALIANT registry. (2005) (21)
Gender differences in therapeutic recommendation after diagnostic coronary angiography: insights from the Coronary Angiography and PCI Registry of the German Society of Cardiology (2015) (21)
Improvement of renal dysfunction in rats with chronic heart failure after myocardial infarction by treatment with the endothelin A receptor antagonist, LU 135252 (2000) (21)
The 140-kD isoform of CD56 (NCAM1) directs the molecular pathogenesis of ischemic cardiomyopathy. (2013) (21)
Cardiac dysfunction and development of heart failure. (1993) (21)
Symptom patterns and clinical outcomes in women versus men with systolic heart failure and depression (2018) (20)
Temporal changes in total and hippocampal brain volume and cognitive function in patients with chronic heart failure—the COGNITION.MATTERS-HF cohort study (2021) (20)
Adaptation to cardiac dysfunction after myocardial infarction. (1993) (20)
Inhibition of platelet activation in rats with severe congestive heart failure by a novel endothelial nitric oxide synthase transcription enhancer (2009) (19)
Increased Cytochrome P4502E1 Expression and Altered Hydroxyeicosatetraenoic Acid Formation Mediate Diabetic Vascular Dysfunction (2010) (19)
Differential Effects of 17β-Estradiol and of Synthetic Progestins on Aldosterone-Salt–Induced Kidney Disease (2009) (19)
High evening salivary cortisol is an independent predictor of increased mortality risk in patients with systolic heart failure. (2016) (19)
Direct measurement of spin‐lattice relaxation times of Phosphorus Metabolites in Human Myocardium (1992) (19)
Predicting 10-Year Risk of Fatal Cardiovascular Disease in Germany: An Update Based on the SCORE-Deutschland Risk Charts (2016) (19)
Aggravation of left ventricular dilatation and reduction of survival by a calcium channel blocker in rats with chronic myocardial infarction. (1993) (19)
Ventricular remodeling after myocardial infarction and effects of ACE inhibition on hemodynamics and scar formation in SHR. (2002) (19)
Does FXIII Deficiency Impair Wound Healing after Myocardial Infarction? (2006) (19)
Increased myocardial oxygen consumption by TNF-α is mediated by a sphingosine signaling pathway (2003) (18)
High-dose 17beta-estradiol treatment prevents development of heart failure post-myocardial infarction in the rat. (2007) (18)
Depressive symptoms in heart failure: Independent prognostic factor or marker of functional status? (2015) (18)
The proinflammatory cytokines TNF-alpha and IL-1 beta impair economy of contraction in human myocardium. (2007) (18)
Changes of atrial natriuretic peptide in brain areas of rats with chronic myocardial infarction. (1996) (18)
Device-based impedance measurement is a useful and accurate tool for direct assessment of intrathoracic fluid accumulation in heart failure. (2010) (18)
[The German National Disease Management Guideline "Chronic Heart Failure"]. (2012) (18)
Effects of serelaxin in patients admitted for acute heart failure: a meta‐analysis (2019) (18)
On the mechanism of renin release during experimental myocardial ischaemia (1985) (17)
Effects of ACE inhibition and beta-receptor blockade on energy metabolism in rats postmyocardial infarction. (1999) (17)
Cost-effectiveness and cost-utility of a structured collaborative disease management in the Interdisciplinary Network for Heart Failure (INH) study (2015) (17)
Role of p38 mitogen‐activated protein kinase in cardiac remodelling (2007) (17)
High dose aspirin and left ventricular remodeling after myocardial infarction (2007) (17)
31P-NMR spectroscopy of human blood and serum: first results from volunteers and patients with congestive heart failure, diabetes mellitus and hyperlipidaemia (1993) (16)
BOLD-MRI in ten patients with coronary artery disease: evidence for imaging of capillary recruitment in myocardium supplied by the stenotic artery (2007) (16)
Prognostic value of aldosterone and cortisol in patients hospitalized for acutely decompensated chronic heart failure with and without mineralocorticoid receptor antagonism. (2015) (16)
Point-of-care B-type natriuretic peptide and portable echocardiography for assessment of patients with suspected heart failure in primary care: rationale and design of the three-part Handheld-BNP program and results of the training study (2018) (16)
Endothelin receptor antagonists in heart failure: current status and future directions. (2004) (16)
Sleep-disordered breathing and heart failure a dangerous liaison. (2008) (16)
Effects of Nifedipine and Indomethacin on Leukotriene C4‐ and D4‐Induced Coronary Constriction at Normal and Reduced Coronary Perfusion in Dogs (1986) (15)
Effects of Endothelin-1 in the Isolated Heart Under Ischemic and Cardioplegic Conditions (1990) (15)
The Year in Cardiology 2013: heart failure. (2014) (15)
23Na MRI combined with contrast‐enhanced 1H MRI provides in vivo characterization of infarct healing (2005) (15)
Prevalence of severe mitral regurgitation eligible for edge-to-edge mitral valve repair (MitraClip) (2016) (15)
Angiotensin converting enzyme inhibitors and ischaemic heart disease. (1988) (15)
Detrimental effects of testosterone on post-myocardial infarction remodelling in female rats. (2007) (15)
[Angiotensin-converting enzyme inhibitors and ischemic heart disease]. (2008) (15)
A functional variant of the neuropeptide S receptor‐1 gene modulates clinical outcomes and healthcare utilization in patients with systolic heart failure: results from the Interdisciplinary Network Heart Failure (INH) Study (2017) (14)
Heart failure in patients with coronary heart disease: Prevalence, characteristics and guideline implementation – Results from the German EuroAspire IV cohort (2017) (14)
Association and diagnostic utility of diastolic dysfunction and myocardial fibrosis in patients with Fabry disease (2018) (14)
Efficacy of a web-based intervention for improving psychosocial well-being in patients with implantable cardioverter-defibrillators: the randomized controlled ICD-FORUM trial (2019) (14)
Effect of chronic heart failure on nuclear factor kappa B in peripheral leukocytes. (2004) (14)
Functional differences of left ventricular hypertrophy induced by either arterial hypertension or aortic valve stenosis. (2008) (14)
The omega-3 index in patients with heart failure: A prospective cohort study. (2019) (14)
Simple screening tools predict death and cardiovascular events in patients with rheumatic disease (2018) (14)
Organic nitrates differentially modulate circulating endothelial progenitor cells and endothelial function in patients with symptomatic coronary artery disease. (2011) (14)
COVID-19 Induced Acute Respiratory Distress Syndrome—A Multicenter Observational Study (2020) (13)
A functional genetic variation of SLC6A2 repressor hsa-miR-579-3p upregulates sympathetic noradrenergic processes of fear and anxiety (2018) (13)
Impella CP use in patients with non‐ischaemic cardiogenic shock (2019) (13)
Impaired resting perfusion in viable myocardium distal to chronic coronary stenosis in rats. (2005) (13)
Impact of different bone marrow cell preparations on left ventricular remodelling after experimental myocardial infarction (2008) (13)
Remodeling of the infarct territory in the time course of infarct healing in humans (2011) (13)
Heart rate reduction by zatebradine reduces infarct size and mortality but promotes remodeling in rats with experimental myocardial infarction. (2004) (13)
Selective modulation of endogenous nitric oxide formation in ischemia/reperfusion injury in isolated rat hearts (2003) (13)
The effects of atrial fibrillation on coronary blood flow and performance of ischaemic myocardium in dogs with coronary artery stenosis. (1987) (13)
Interactions between coronary occlusion and the renin-angiotensin system in the dog (1983) (13)
A collagen α2(I) mutation impairs healing after experimental myocardial infarction. (2012) (12)
Alpha-receptor constriction induced by atrial fibrillation during maximal coronary dilatation (2005) (12)
Prognostic impact of diastolic dysfunction in systolic heart failure—A cross‐project analysis from the German Competence Network Heart Failure (2017) (12)
The dependence of coronary collateral blood flow on regional vascular resistances (1979) (12)
A multinational registry to study the characteristics and outcomes of heart failure patients: The global congestive heart failure (G-CHF) registry. (2020) (12)
ACE inhibition after myocardial infarction: can megatrials provide answers? (1994) (12)
Exogenous Administration of a Recombinant Variant of TWEAK Impairs Healing after Myocardial Infarction by Aggravation of Inflammation (2013) (12)
Changes of myocardial high‐energy phosphates with the cardiac cycle during acute or chronic myocardial stress (1998) (12)
Microvascular adaptation to coronary stenosis in the rat heart in vivo: a serial magnetic resonance imaging study. (2003) (11)
Value of the CHA2DS2-VASc score and Fabry-specific score for predicting new-onset or recurrent stroke/TIA in Fabry disease patients without atrial fibrillation (2018) (11)
Reduced basal nitric oxide bioavailability and platelet activation in young spontaneously hypertensive rats. (2004) (11)
Influence of angiotensin-converting enzyme inhibition on cardiac function in myocardial infarction. (1990) (11)
Rationale, design, and baseline participant characteristics in the MRI and cognitive substudy of the cardiovascular outcomes for people using anticoagulation strategies trial (2018) (11)
Angiotensin I conversion and coronary constriction by angiotensin II in ischemic and hypoxic isolated rat hearts. (1991) (11)
Chronic effects of ACE-inhibition (quinapril) and angiotensin-II type-1 receptor blockade (losartan) on atrial natriuretic peptide in brain nuclei of rats with experimental myocardial infarction (2001) (11)
Effects of neurotensin and neuropeptide Y on coronary circulation and myocardial function in dogs. (1993) (11)
Coronary arteriolar vasoconstriction in myocardial ischaemia. Vasopressin, renin-angiotensin system and ANF. (1990) (11)
[Evidence-based disease management in patients with heart failure (HeartNetCare-HF Würzburg)]. (2009) (11)
Early citalopram treatment increases mortality due to left ventricular rupture in mice after myocardial infarction. (2016) (11)
Cardiac sarcoidosis—clinical and immunoserologic studies (1987) (11)
Secondary Prevention in Younger vs. Older Coronary Heart Disease Patients—Insights from the German Subset of the EUROASPIRE IV Survey (2018) (11)
Angiotensin-Converting Enzyme Inhibition and Endothelin Antagonism for Endothelial Dysfunction in Heart Failure: Mono-or Combination Therapy (2002) (11)
The Fabry cardiomyopathy - diagnostic approach and current treatment. (2014) (11)
[Experimental and clinical possibilities of MR spectroscopy of the heart]. (1991) (11)
Functional mechanisms of myocardial microcirculation in left ventricular hypertrophy: a hypothetical model of capillary remodeling post myocardial infarction. (2008) (10)
Non-Invasive Functional and Biochemical Assessment of Mitoxantrone Cardiotoxicity in Patients with Multiple Sclerosis (2003) (10)
Increased myocardial oxygen consumption by TNF-alpha is mediated by a sphingosine signaling pathway. (2003) (10)
Mega‐trials in heart failure: effects of dilution in examination of new therapies (2020) (10)
Electrical Changes in Resting, Exercise, and Holter Electrocardiography in Fabry Cardiomyopathy. (2015) (10)
Effect of quinapril initiated during progressive remodeling in asymptomatic patients with healed myocardial infarction. (2000) (10)
Effect of transmyocardial laser revascularization on myocardial perfusion and left ventricular remodeling after myocardial infarction in rats. (2002) (10)
Factors associated with smoking cessation in patients with coronary heart disease: a cohort analysis of the German subset of EuroAspire IV survey (2020) (10)
Natriuretic peptides and myocardial oxygen supply‐to‐demand ratio in patients with aortic stenosis (2007) (10)
Compensatory mechanisms for cardiac dysfunction in myocardial infarction. (1991) (10)
Saturday, 25 August 2012 (2012) (9)
Adverse cardiac remodeling: phosphoinositide 3-kinase, another unique factor in a multifactorial condition. (2012) (9)
Regional differences in precipitating factors of hospitalization for acute heart failure: insights from the REPORT‐HF registry (2022) (9)
Echocardiographic Determinants of One-Year All-Cause Mortality in Patients With Chronic Heart Failure Complicated by Significant Functional Tricuspid Regurgitation. (2017) (9)
Prognostic significance of serial high-sensitivity troponin I measurements following acute cardiac decompensation-correlation with longer-term clinical outcomes and reverse remodelling. (2017) (9)
Trajectories of Left Ventricular Ejection Fraction After Acute Decompensation for Systolic Heart Failure: Concomitant Echocardiographic and Systemic Changes, Predictors, and Impact on Clinical Outcomes (2021) (8)
EFFECTS OF LEUKOTRIENE-D4 AND ITS SPECIFIC ANTAGONIST L-660, 711 IN ISOLATED RAT-HEART WITH CHRONIC MYOCARDIAL-INFARCTION (1992) (8)
Morbus Fabry of the heart. Why should cardiologists care? (2005) (8)
[Iron Deficiency in Chronic Heart Failure: Diagnostic Algorithm and Present-Day Therapeutic Options]. (2017) (8)
A translational approach to myocardial remodelling. (2008) (8)
Post-COVID Syndrome. (2023) (8)
Intracardial dislocation of a cranio-peritoneal shunt in a 6-year-old boy (2010) (8)
CRP genetic variants are associated with mortality and depressive symptoms in chronic heart failure patients (2018) (8)
Temporal fluctuations of myocardial high-energy phosphate metabolites with the cardiac cycle (2001) (8)
Pathologic endothelial response and impaired function of circulating angiogenic cells in patients with Fabry disease (2012) (8)
Functional properties and [Ca(2+)](i) metabolism of creatine kinase--KO mice myocardium. (2002) (8)
Three‐dimensional coronary angiography of the perfused rat heart (1997) (8)
Interrelation of coronary effects of atrial natriuretic peptide and the renin-angiotensin system in the isolated perfused rat heart. (1994) (8)
Dobutamine induces ineffective work in regional ischaemic myocardium: an experimental strain rate imaging study. (2004) (8)
Effects of High- and Low-Dose Amiodarone on Mortality, Left Ventricular Remodeling, and Hemodynamics in Rats with Experimental Myocardial Infarction (2004) (7)
[Differential diagnosis of dyspnea - significance of clinic aspects, imaging and biomarkers for the diagnosis of heart failure]. (2006) (7)
Interference of Angiotensin‐Converting Enzyme Inhibition with Vasoactive Peptides in the Coronary Circulation of Dogs (1995) (7)
Impact of Thoracic Surgery on Cardiac Morphology and Function in Small Animal Models of Heart Disease: A Cardiac MRI Study in Rats (2013) (7)
Long-term intravenous inotropes in low-output terminal heart failure? (2016) (7)
Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease (2021) (7)
Morbus Fabry of the heart (2005) (7)
Endothelium-dependent and -independent vasoreactivity of rat basilar artery in chronic heart failure. (2000) (7)
Alpha-adrenergic vasoconstriction in arterial and arteriolar sections of the canine coronary circulation (1980) (7)
Rivaroxaban for Prevention of Covert Brain Infarcts and Cognitive Decline (2020) (7)
[Adamantiades-Behçet's disease. Clinical review]. (2008) (7)
Noninvasive Imaging of Angiogenesis Inhibition Following Nitric Oxide Synthase Blockade in the Ischemic Rat Heart in Vivo (2005) (7)
Case report of a 45-year old female Fabry disease patient carrying two alpha-galactosidase A gene mutation alleles (2016) (7)
Biomarkers in Heart Failure – Better than History or Echocardiography? (2009) (7)
Global Differences in Burden and Treatment of Ischemic Heart Disease in Acute Heart Failure: REPORT-HF. (2021) (7)
Erratum: Cardiac RKIP induces a beneficial β-adrenoceptor–dependent positive inotropy (2016) (7)
Temporal fluctuations of myocardia high-energy phosphate metabolite with the cardiac cycle. (2001) (7)
Effects of JNJ-54452840, an Anti-ÃÂ²1 Receptor Antibody Cyclopeptidein Heart Failure Patients: A Randomized, Double-blind, Parallel-group,Phase-2 Pilot Study (2016) (7)
Impaired platelet responses to clopidogrel and ticlopidine in a patient with recurrent coronary stent stenosis (2004) (6)
[31P-cardio-MR-spectroscopy in myocardial insufficiency]. (1993) (6)
Clubbing due to peripheral hypervascularization: recognition by contrast-enhanced, three-dimensional magnetic resonance angiography. (2001) (6)
Effects of LTD4 and its specific antagonist L-660,711 in isolated rat hearts with chronic myocardial infarction. (1994) (6)
Escitalopram and Outcomes Among Patients With Depression and Heart Failure-Reply. (2016) (6)
Sensitivity and Specificity of Transesophageal Echocardiography in the Diagnosis of Vegetations and Abscesses in Infective Endocarditis (1989) (6)
Impact of diastolic dysfunction on outcome in heart failure patients with mid‐range or reduced ejection fraction (2021) (6)
Development, early treatment, and prevention of heart failure. Introduction. (1993) (6)
Command and control in hospitals during SARS-CoV-2 pandemic: The windmill model of disaster response. (2020) (6)
Physicians' lifestyle advice on primary and secondary cardiovascular disease prevention in Germany: A comparison between the STAAB cohort study and the German subset of EUROASPIRE IV. (2019) (6)
Quality of life assessed 6 months after hospitalisation for acute heart failure: an analysis from REPORT‐HF (international REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure) (2022) (6)
Sex‐specific bimodal clustering of left ventricular ejection fraction in patients with acute heart failure (2021) (6)
[Science based medicine]. (2016) (6)
New insight into healing mechanisms of the infarcted heart. (2010) (6)
Failure to Unmask Pseudonormal Diastolic Function by a Valsalva Maneuver: Tricuspid Insufficiency Is a Major Factor (2011) (6)
Two-dimensional transesophageal echocardiography for aortic annular sizing in patients undergoing transcatheter aortic valve implantation (2015) (6)
Systolic Blood Pressure and Outcome in Patients Admitted With Acute Heart Failure: An Analysis of Individual Patient Data From 4 Randomized Clinical Trials (2021) (6)
Cardiac JAK2 mutation V617F in a patient with cardiomyopathy and myeloproliferative disease. (2008) (5)
Exogenous surfactant application in respiratory failure due to chronic obstructive pulmonary disease. (1995) (5)
Medroxyprogesterone Acetate Aggravates Oxidative Stress and Left Ventricular Dysfunction in Rats with Chronic Myocardial Infarction (2011) (5)
Clinical characteristics, treatment and survival in patients with systolic heart failure--comparative assessment of a Chinese and a German cohort. (2014) (5)
Sunday, 26 August 2012 (2012) (5)
Antibodies to cardiac receptors (2012) (5)
[Assessment of diastolic heart failure. Current role of echocardiography]. (2013) (5)
Mechanisms of the effects of nicorandil in the isolated rat heart during ischemia and reperfusion: a 31P-nuclear magnetic resonance study. (2001) (5)
Growth hormone treatment improves markers of systemic nitric oxide bioavailability via the insulin-like growth factor-1 Importance for endothelial progenitor cells. (2007) (5)
Coagulation factor XIII activity predicts left ventricular remodelling after acute myocardial infarction (2020) (5)
Potential role of mixed ACE and neutral endopeptidase inhibitor in the treatment of heart failure. (1999) (5)
Functional assessment of isolated right heart failure by high resolution in-vivo cardiovascular magnetic resonance in mice. (2007) (5)
Trauma induced by nontraumatic coronary devices and its impact on vascular reactivity and morphology. (2002) (5)
Initial clinical application of real-time MR imaging-guided ablation of cardiac arrhythmia in patients with atrial flutter. (2014) (5)
S ustained activation of nuclear factor kappa B and activator protein 1 in chronic heart failure (2003) (5)
[A successful procedure in mitral valve rupture accompanied by rupture of the papillary muscle and the chordae tendinae following multiple injuries and blunt thoracic trauma]. (1989) (5)
Prevalence of cardiovascular risk factors and diseases in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation (2019) (5)
Value of cardiac biomarker measurement in the differential diagnosis of infiltrative cardiomyopathy patients with preserved left ventricular systolic function. (2018) (5)
[Holistic therapy of chronic heart failure]. (2014) (5)
Ultrasonic strain rate imaging can predict the recovery of function after acute myocardial infarction and assess the transmurality of scar in chronic infarctions (2004) (4)
Remodelling and adverse remodelling in CAD (2012) (4)
On the range of α-adrenergic regulation of coronary vascular resistance (1979) (4)
[Cardiac arrhythmias in the chronic phase of myocardial infarction (author's transl)]. (1976) (4)
Effects of ischemia on myocardial function during rapid left ventricular pacing. (2006) (4)
[Depression and heart failure - a dangerous combination]. (2016) (4)
[Cardiac remodeling after myocardial infarction : Clinical practice update]. (2017) (4)
Cardiac regeneration by progenitor cells – bedside before bench? (2005) (4)
Cumulative Prognostic Benefit of Classical Cardiovascular Risk Factors (2009) (4)
[The overexpression of NCAM (CD56) in human hearts is specific for ischemic damage]. (2004) (4)
Angiotensin II subtype 1 (AT1) receptors contribute to ischemic contracture and regulate chemomechanical energy transduction in isolated transgenic rat (αMHC‐hAT1)594–17 hearts (2002) (4)
Using simple imaging markers to predict prognosis in patients with aortic valve stenosis and unacceptable high risk for operation. (2013) (4)
Reference values for aortic diameters obtained using both inner-edge-to-inner-edge and leading-edge-to-leading-edge methods in 190 healthy subjects (2012) (4)
Detection of myocardial viability in acute infarction using contrast-enhanced 1H magnetic resonance imaging (2003) (4)
Coronary Effects of Leukotrienes C4 and D4 at Normal and Reduced Coronary Perfusion (1985) (4)
Left Ventricular Function During VVI and DVI Pacing at Different Rates as Assessed by M-Mode and Two-Dimensional Echocardiography, Gated Single Photon Emission Computerized Tomography (GASPECT) and Thermodilution (1985) (3)
On the range of alpha-adrenergic regulation of coronary vascular resistance. (1979) (3)
Acute episode of an arrhythmogenic right ventricular cardiomyopathy with vast necroses exclusively in right ventricular myocardium (2009) (3)
Eikosanoid effects on coronary blood flow and ischaemic myocardium (1987) (3)
Endothelin Receptor Antagonists in Heart Failure (2012) (3)
Clinical impact of the alpha-galactosidase A gene single nucleotide polymorphism -10C>T (2018) (3)
Exercise, eNOS and the heart after myocardial infarction. (2010) (3)
[Monogenic heart disease]. (2008) (3)
Long-term reduction of mortality in the 4-year follow up of tirofiban therapy in elective percutaneous coronary interventions (TOPSTAR) trial. (2011) (3)
Left Ventricular Remodelling during Treatment with β-Blockers (1999) (3)
[Low flow/low gradient aortic valve stenosis : clinical and diagnostic management]. (2013) (3)
Remodeling of the brain post myocardial infarction: Focus on central ANF (1997) (3)
Dynamics of left ventricular myocardial work in patients hospitalized for acute heart failure. (2021) (3)
A model for the investigation of regional coronary vascular resistances Physical features as compared with experimental results (1980) (3)
Correction to: Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort study. (2020) (3)
EFFECTS OF LEUKOTRIENE-D4 AND ITS SPECIFIC ANTAGONIST L-660,711 IN ISOLATED RAT-HEART AFTER MYOCARDIAL-INFARCTION (1992) (3)
Reproducibility of in‐hospital worsening heart failure event adjudication in the RELAX‐AHF‐EU trial (2019) (3)
Monday, 27 August 2012 (2012) (3)
Functional effects and molecular mechanisms of subtype-selective ERalpha and ERbeta agonists in the cardiovascular system. (2006) (3)
Downregulation of the Na 1-Creatine Cotransporter in Failing Human Myocardium and in Experimental Heart Failure (1999) (3)
Prevalence and prognostic impact of chronic kidney disease and anaemia across ACC/AHA precursor and symptomatic heart failure stages (2022) (3)
A new porcine model of hypertensive cardiomyopathy: a helpful tool to explore the HFpEF mystique. (2015) (3)
Morbus Adamantiades-Behçet (2008) (3)
[Development of heart failure after myocardial infarct]. (1991) (2)
University of Groningen Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency Ponikowski, (2015) (2)
Public funding for medical research in relation to the burden of disease caused by cardiovascular diseases and neoplasms in Germany (2018) (2)
99 Supra‐regional success of a structured training program for general practitioners enabling performance of handheld echocardiography and point‐of‐care BNP testing and use for heart failure diagnosis (2007) (2)
Advances in managing heart failure and suddencardiac death: reverse remodelling by drugs? (2003) (2)
Mortality risk prediction by cortisol and aldosterone in chronic heart failure (2007) (2)
Left Ventricular Assessment in Myocardial Infarction (2013) (2)
195 Improvement of cardiac function during enzyme replacement therapy in patients with fabry disease. A prospective strain rate imaging studie (2003) (2)
[Competence Network Heart Failure (CNHF). Together against heart failure]. (2016) (2)
[In vivo 31P-cardiac magnetic resonance spectroscopy: methods and the first clinical results]. (1991) (2)
Reply to: Questionnaire survey on depression for patients with heart failure: validation for selecting appropriate cut-off points. (2013) (2)
Abstract 12895: Characteristics and Outcome of Ventricular Tachycardia in Advanced Fabry Disease Cardiomyopathy (2016) (2)
Rationale , Design and Baseline Characteristics of Participants in the C ardiovascular O utco m es for P eople Using A nticoagulation S trategie s ( COMPASS ) Trial (2017) (2)
Systematic Echocardiographic Evaluation of Mitral Valve Regurgitation for Transcatheter Edge‐to‐Edge Repair (2016) (2)
Observations on the experimental reduction of infarct size and on the delayed consequences of transient myocardial ischemia. (2009) (2)
Increased mortality and aggravation of heart failure in ERB knock out mice following myocardial infarction (2005) (2)
673 Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure (2007) (2)
IMPAIRED CARDIAC HIGH-ENERGY PHOSPHATE-METABOLISM IN PATIENTS WITH AORTIC-VALVE DISEASE - CLINICAL AND HEMODYNAMIC CORRELATES (1993) (2)
Aldosterone: from integrative physiology to cellular biology and back (2004) (2)
Long-term calcium-channel blockade causes left ventricular dilation in asymptomatic patients with chronic infarction (1996) (2)
Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open Label Extension of the COMPASS trial. (2022) (2)
Poster Session: Right ventricular systolic function (2012) (2)
Angiotensin II Type 1 receptor induced signal-transduction pathways as new targets for pharmacological treatment of the renin-angiotensin system (2004) (2)
[Diagnostics and treatment of chronic heart failure : Update 2020]. (2020) (2)
[Heart Failure - A Model for Multimorbidity]. (2017) (2)
Frequency and prognostic impact of mid-expiratory flow reduction in stable patients six months after hospitalisation for heart failure with reduced ejection fraction. (2017) (2)
[The direct measurement of the spin-grid-relaxation times of phosphorus metabolites in the human myocardium]. (1992) (2)
Variations in cardiovascular risk factors in people with and without migration background in Germany - Results from the STAAB cohort study. (2019) (2)
Poster session Wednesday 11 December all day display: 11/12/2013, 09:30-16:00 * Location: Poster area (2013) (2)
Pericardial thickness and pericardial effusion as echocardiographic markers of acute or past pericardial, perimyocardial and myocardial disease (1987) (2)
Myocardial contractile efficiency increases in proportion to a fetal enzyme shift in chronically infarcted rat hearts (2005) (2)
Association of time‐to‐intravenous furosemide with mortality in acute heart failure: data from REPORT‐HF (2022) (2)
Cardiac amyloidosis mimicking severe aortic valve stenosis – a case report demonstrating diagnostic pitfalls and role of dobutamine stress echocardiography (2017) (2)
Abstract 3706: NO Independent Activation of Soluble Guanylyl Cyclase Provides Additional Benefit to ACE Inhibition on Cardiac Remodeling Postinfarction (2009) (2)
[Aldosterone receptor blockade after acute myocardial infarction with heart failure]. (2006) (2)
[The various forms of left ventricular hypertrophy: diagnostic value of echocardiography]. (2011) (2)
Less loop diuretic use in patients on sacubitril/valsartan undergoing remote pulmonary artery pressure monitoring (2021) (2)
Value of low-dose dobutamine stress echocardiography on defining true severe low gradient aortic stenosis in patients with preserved left ventricular ejection fraction (2018) (2)
Determinants of coronary effects of atrial natriuretic factor in dogs (1992) (2)
Poster session Friday 13 December - PM: 13/12/2013, 14:00-18:00 * Location: Poster area (2013) (2)
Deterioration of metabolic coronary regulation in hemorrhagic shock (1985) (2)
P6421Role of sudden cardiac death as end-stage complication in Fabry disease cardiomyopathy: Impact of primary and secondary prophylactic ICD therapy on long-term outcome (2017) (1)
Abstract 807: Directly Assessed Pulmonary Fluid Overload in Acute Cardiac Decompensation Shows a Strong Correlation with Device-Based Measurement of Intrathoracic Impedance (2008) (1)
Systemic thrombolysis in acute myocardial infarction with prourokinase and urokinase (STAMP): Results of a randomized multicenter study (1990) (1)
Predictive value of systolic and diastolic strain rate for survival in cardiac amyloidosis patients with preserved ejection fraction (2014) (1)
Functional versus morphological assessment of vascular age in patients with coronary heart disease (2021) (1)
Longer-Term Effects of Remote Patient Management Following Hospital Discharge After Acute Systolic Heart Failure: The Randomized E-INH Trial. (2023) (1)
Poster Session 5The imaging examination and quality assessment. (2016) (1)
Association between Comorbidities and Progression of Transvalvular Pressure Gradients in Patients with Moderate and Severe Aortic Valve Stenosis (2018) (1)
[Internal medicine is more than the sum of its subspecialties]. (2011) (1)
Enhancer AVE9488 After Experimental Myocardial Infarction Improvement in Left Ventricular Remodeling by the Endothelial Nitric Oxide Synthase (2008) (1)
Short communication Is health-related quality of life an independent predictor of survival in patients with chronic heart failure? ☆ (2007) (1)
Failure of recombinant human growth hormone treatment to improve congestive heart failure in hypopituitarism. (2004) (1)
Iron deficiency is associated with impaired quality of life in non-anaemic patients hospitalized for acute decompensated heart failure (2013) (1)
Echocardiographic risk factors of left ventricular thrombus in patients with acute anterior myocardial infarction (2021) (1)
[Heart involvement in Friedreich's ataxia]. (2015) (1)
506 Doppler myocardial imaging differentiates myocardial hypertrophy induced either by arterial hypertension or aortic stenosis (2003) (1)
Moderated Posters session * New insights into risk stratification in valvular heart disease - Part A: 11/12/2013, 09:30-16:00 * Location: Moderated Poster area (2013) (1)
Real‐time Triggered RAdial Single‐Shot Inversion recovery for arrhythmia‐insensitive myocardial T1 mapping: motion phantom validation and in vivo comparison (2018) (1)
Book Review Difficult Cardiology III Edited by Graham Jackson. 419 pp., illustrated. London, Martin Dunitz, 1997. (Distributed by Mosby, St. Louis.) $99.50. 1-85317-406-8 (1998) (1)
Adaptive anti‐myocardial immune response following hospitalization for acute heart failure (2021) (1)
Prevention by angiotensin converting enzyme inhibitors (1992) (1)
Changes of collateral perfusion pressure and segmental coronary resistances during reactive hyperemia in anesthetized dogs (1983) (1)
Prevention of hypertensive crises in rats induced by acute and chronic norepinephrine excess. (2010) (1)
[Do We Need a Specialist Physician for Digital Medicine?] (2018) (1)
Potentials of ACE-inhibitor therapy in acute myocardial ischemia (1991) (1)
[Large left ventricular aneurysm after silent myocardial infarction. Documentation by serial non-invasive imaging]. (2008) (1)
ANTI-ISCHEMIC AND FIBRINOLYTIC EFFECTS OF ANGIOTENSIN' CONVERTING-ENZYME INHIBITORS : REVIEW OF CLINICAL EVIDENCES (1997) (1)
[Heart failure networks and centers : What does everyday life look like?] (2018) (1)
[Acute heart failure - a unique challenge]. (2015) (1)
Serial apical deformation change is predictive of outcome in patients with cardiac amyloidosis (2014) (1)
Segmental metabolic responses of the canine coronary circulation (1981) (1)
Erratum: Cardiac RKIP induces a beneficial β-adrenoceptor–dependent positive inotropy (2016) (1)
Tuesday, 28 August 2012 (2012) (1)
Heart failure classification in clinical practice: time to redefine? (2022) (1)
Medroxyprogesterone-acetate but not drospirenone ablates the protective function of 17b-estradiol against cardiovascular injury in aldosterone-treated rats (2006) (1)
Myocardial perfusion and capillary blood volume during left ventricular remodelling (1998) (1)
115 Combination‐therapy with neutralizing cyclopeptides and beta‐blockers decreases molecular markers of sympathetic activation and reverses cardiomyopathy in beta1‐receptor antibody‐induced heart failure (2007) (1)
[Heart failure in the general medical practice - A guide to diagnosis and therapy]. (2018) (1)
[Beta receptor blocker for therapy of chronic cardiac insufficiency. A vision of clinical pharmacology]. (2008) (1)
[Transition of myocardial ischemia to heart failure]. (1998) (1)
FatalAspergillus fumigatus septicemia in a patient with an ectopic ACTH-producing neuroendocrine pancreatic tumor (1999) (1)
Abstract 228: Alterations of Cardiac Morphology and Function Caused by Cardio-Thoracic Surgery in Small Animal Models of Heart Disease (2013) (1)
[Magnetic resonance spectroscopy of the heart. Its clinical importance]. (2008) (1)
[Therapy of chronic heart failure--carvedilol vs. metoprolol. COMET Study]. (2004) (1)
Effect of mediators on coronary circulation. (1991) (1)
Blood Pressure Drops During Hospitalization for Acute Heart Failure Treated With Serelaxin: A Patient-Level Analysis of 4 Randomized Controlled Trials (2022) (1)
activation and adhesion Novel role of the membrane-bound chemokine fractalkine in platelet (2010) (1)
104 A novel receptor‐homologous cyclic peptide prevents beta1‐adrenoceptor antibody‐induced progressive cardiomyopathy (2005) (1)
A Global Perspective of Racial Differences and Outcomes in Patients Presenting with Acute Heart Failure. (2021) (1)
The German Cardiac Society and development of cardiovascular research and medicine in Germany. (2013) (1)
P.1.h.043 Chronic heart failure and depression: anhedonia, motivation deficits, and functional brain changes in mice with myocardial infarction (2014) (1)
CREATINE-KINASE FLUX IS DOWN-REGULATED IN CHRONICALLY INFARCTED RAT-HEART (1993) (1)
Rationale and design of the CONFIRM-HF study: a double-blind, randomized, placebo-controlled study to assess the effects of intravenous ferric carboxymaltose on functional capacity in patients with chronic heart failure and iron deficiency: Rationale and design of CONFIRM-HF study (2014) (1)
[Modification of hemodynamics by angiotensin converting enzyme inhibitors in heart failure]. (1990) (1)
[Epidemiology and prognosis of myocardial infarct and chronic heart failure]. (1993) (1)
Strong overexpression of NCAM(CD56) is specific for human ischemic cardiomyopathy and might be regulated by two novel isoforms of RUNX1(AML1) (2004) (1)
Prognostic value of global longitudinal strain versus mitral annular plane systolic excursion in patients with ischemic heart failure (2020) (1)
372 Transforming growth factor inhibition increases mortality and left ventricular dilatation after myocardial infarction (2007) (1)
Novel role for the membrane-bound chemokine fractalkine: A pathophysiologically relevant mechanism in platelet activation and adhesion (2003) (1)
[The basis for our actions]. (2014) (1)
How to distinguish between physiological and pathological post-systolic-thickening. An experimental strain rate imaging study (2005) (1)
Coronary Artery Bypass Surgery on the Beating Heart by the Aid of a Novel Perfusion Balloon Catheter (1998) (1)
Regional variation of effects of new antidiabetic medications in cardiovascular outcome trials. (2021) (1)
[Seroprevalence of COVID-19 and Psychosocial Effects in the General Population: Results of the STAAB-COVID-One Program]. (2021) (1)
Cardiac 31P-MR-spectroscopy in myocardial insufficiency (1993) (1)
584 Prevention of cardiac hypertrophy and failure in vivo by a novel microRNA antagonist (2008) (1)
Global disparities in prescription of guideline-recommended drugs for heart failure with reduced ejection fraction. (2022) (1)
Innate Immunity in Heart Failure (2008) (1)
MODERATED POSTER SESSION: Imaging in cardiomyopathies: Friday 5 December 2014, 08:30-18:00Location: Moderated Poster area. (2014) (1)
[Revascularization in patients with type 2 diabetes and coronary artery disease: BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) Study Group]. (2010) (0)
P1691Enlarged left atrium is an independent risk factor for long-term mortality in heart failure patients with reduced ejection fraction and received implantable cardioverter defibrillators (2017) (0)
4100Selective TRASSI T1 mapping for improved endocardial and right ventricular diagnostics (2017) (0)
Abstract 16979: Impact of ICD Shock Testing and Non-Testing on Arrhythmia Therapy Efficacy (2011) (0)
[The problem of rare diseases: a challenge for teaching, research and patient care]. (2008) (0)
[Medicine in a free market]. (2012) (0)
Wednesday, 29 August 2012 (2012) (0)
Towards a Fruitful Discussion on a Multi-faceted and Complex Topic in Echocardiography: Response to the Letter to the Editor (2011) (0)
Direct measurements of relaxation times of phosphorus metabolites in the human myocardium (1992) (0)
P904 Impact of significant functional mitral regurgitation and aortic stenosis on outcome of HFrEF patients (2020) (0)
411 Recompensation induces distinct changes in myocardial work in patients with acutely decompensated heart failure and reduced vs preserved left ventricular ejection fraction (2020) (0)
[The unity of internal medicine must be preserved and cultivated]. (2011) (0)
[Centers in Health Care: whereto?] (2017) (0)
The role of endothelial nitric oxide synthase (eNOS) in endothelial activation: insights from eNOS-knockout endothelial cells (2004) (0)
Loss of creatine in heart failure. A loss-win situation? (2010) (0)
The true T1 values of myocardial high‐energy phosphates? (1993) (0)
Interpretation of Clinical Trials in the Context of Personalized/Individualized Medicine and End of Life Issues (2019) (0)
[Opening address of the 114th Congress of the Germany Society for Internal Medicine]. (2008) (0)
Therapeutic monitoring of direct oral anticoagulants - back to the future? (2020) (0)
Role of exercise-induced repetitive rise of filling pressure and plasma hormones for advanced progressive remodeling — effect of quinapril (1998) (0)
chronic coronary stenosis in rats Impaired resting perfusion in viable myocardium distal to (2016) (0)
Abstract 17219: Prognostic Impact of Pulmonary Function in Systolic Heart Failure (2012) (0)
The combination of diastolic filling and diastolic deformation predicts mortality in patients with cardiac amyloidosis during serial echocardiography (2015) (0)
[Evidence based medicine and individualized therapy: a contradiction? Primary topic of the 114th Internist Congress 2008]. (2008) (0)
283 Generic health-related quality of life in patients with chronic systolic heart failure: impact of depression (2007) (0)
Determination of left ventricular volume by means of an invasive ultrasonic method (1980) (0)
Acute Myocarditis – A Trigger of Cardiac Autoimmunity? Expected Insights from the Etiology, Titre-Course, and Effect on Survival of Cardiac Autoantibodies (ETiCS) Study (2011) (0)
Abstract 254: Growth Hormone Treatment of Healthy Middle-aged Volunteers Improves Nitric Oxide Bioavailability and Circulating Endothelial Progenitor Cell Levels via Insulin-like Growth Factor-1 (2007) (0)
677 Inhibition of p38 MAP kinase improves endothelial dysfunction in chronic heart failure: role of vascular superoxide anion production (2003) (0)
Abstract 12413: 5-Lipoxygenase Facilitates Healing after Myocardial Infarction (2011) (0)
[From cardiovascular risk to chronic heart failure]. (2008) (0)
Segmental response to sympathetic activation in the canine coronary circulation (1981) (0)
High-rose 17 beta-estradiol treatment prevents development of heart failure post-myocardial infarction in the rat (1999) (0)
YI-807 ENHANCED SYSTEMIC NO BIOAVAILABILITY BY GROWTH-HORMONE MEDIATED IGF-1 INCREASE IMPROVES NUMBER AND FUNCTION OF ENDOTHELIAL PROGENITOR CELLS IN AGED INDIVIDUALS (2007) (0)
VISUALIZATION OF ACUTE AND SUBACUTE EP LESIONS IN PATIENTS AFTER ATRIAL FLUTTER ABLATION (2011) (0)
Distribution pattern of left ventricular ejection fraction in patients with decompensated heart failure depends on sex results of a latent class analysis (2021) (0)
Abstract 2041: Low P2Y12-Specific Platelet Inhibition in Clopidogrel-Treated Patients with Coronary Artery Disease is Common and not Reliably Detected by Conventional Aggregation Tests (2007) (0)
, Thomas study in rat function of remote myocardium : MRI and spectroscopy Chronic coronary artery stenosis induces impaired (2003) (0)
Abstract 3111: Reverse Epidemiology in Chronic Heart Failure: Cumulative Predictive Power of Classical Cardiovascular Risk Factors (2008) (0)
Prognosis in patients with suspected heart failure in primary care - impact of NT-proBNP (2010) (0)
Nocardial endocarditis ofan aortic valve prosthesis (1987) (0)
Prevalence, severity and clinical correlates of left ventricular diastolic dysfunction in patients hospitalized with acute cardiac decompensation – a sub-study from the Acute Heart Failure (2020) (0)
Malfunction of endothelial progenitor cells and endothelial function in patients with Fabry disease. (2007) (0)
Post-discharge prognosis of patients hospitalized for heart failure according to world-region and national levels of income and income-disparity in REPORT-HF: A cohort study (2019) (0)
[Personalized Medicine: A big promise for the future]. (2015) (0)
THE MYOCARDIAL CREATINE-PHOSPHATE ATP RATIO, MEASURED BY 31P-MR SPECTROSCOPY, AS A PREDICTOR OF MORTALITY IN PATIENTS WITH DILATED CARDIOMYOPATHY (1995) (0)
P1102Role of serum biomarkers for monitoring disease progression in the cardio-specific alpha-galactosidase A genotype N215S (2017) (0)
1204 Non-invasive assessment of the contractile reserve in patients with non-severe coronary artery disease — a strain rate imaging study (2005) (0)
Abstract 236: Endothelial Nitric Oxide Production Inhibits Leukocyte Endothelial Cell- But Not Platelet Endothelial Cell Interactions (2007) (0)
Georg Ertl Enhanced Vascular Superoxide Production Endothelial Nitric Oxide Synthase and Soluble Guanylate Cyclase Expression : Role of Endothelial Dysfunction in Chronic Myocardial Infarction Despite Increased Vascular (1999) (0)
Impaired healing in factor XIII KO mice after myocardial infarction assessed by magnetic resonance imaging (2002) (0)
Prognosis and right ventricular function assessment in chronic heart failure with severe tricuspid regurgitations: doppler-derived systolic pulmonary artery pressure is not enough (2013) (0)
Muzolimine therapy in patients with congestive heart failure in comparison with furosemide pretreatment. Effect on digoxin plasma concentration. (1985) (0)
Abstract 2396: Device-Based Heart Failure Management: Multi-Frequency Impedance Measurements to Optimize Intrathoracic Fluid Monitoring (2008) (0)
The concept of cardiac wound healing (2012) (0)
706-6 Endothelin-1 Receptor Antagonists BQ123 and BQ610 Delay Ischemic Contracture, Preserve High-Energy Phosphate Metabolism and Improve Systolic Function During Ischemia/Reperfusion (1995) (0)
Aldosterone mediated dysfunction of human endothelial progenitor cells - Mechanisms and therapeutic opportunities. (2007) (0)
Feasibility of a new method using two-dimensional transesophageal echocardiography for aortic annular sizing in patients undergoing transcatheter aortic valve implantation; a case–control study (2015) (0)
108 Cardioprotective cyclic peptides and beta-blockers in the therapy of beta1-receptor antibody-induced cardiomyopathy: effects on phenotype and cardiac expression of ANP/BNP/Cytokines (2008) (0)
Safety of Asynchronous Ventricular Pacemaker Stimulation (2005) (0)
976 Changes of regional myocardial function and myocardial hypertrophy in patients with severe aortic stenoses during long term follow-up after aortic valve replacement (2006) (0)
The cost-effectiveness of Rivaroxaban with or without aspirin in the COMPASS trial. (2022) (0)
[Clinical advances: research has to reach the patient]. (2011) (0)
Best Practice & Research Clinical Endocrinology & Metabolism (2015) (0)
Determinants of ejection fraction improvement in heart failure patients with reduced ejection fraction (2023) (0)
Do sudden cardiac death rates warrant earlier treatment following myocardial infarction? experience from the VALIANT Trial (2004) (0)
652 Relation between regional deformation properties and myocardial wall thickness in patients with fabry disease. An ultrasonic strain rate imaging study (2003) (0)
P5452First data-analysis of the prospective ETiCS-study after study-end confirms acute (microbial-induced) inflammation as a key trigger for the development of cardiac GPCR-autoantibodies (2019) (0)
Influence of the ischemic coronary bed on collateral blood flow (1982) (0)
Differentiation between new and old intracavitary thrombi by ultrasonic deformation properties (2009) (0)
We-P11:32 Uncoupled endothelial nitric oxide synthase in diabetic bone marrow-impact on endothelial progenitor cells (2006) (0)
[Not Available]. (2016) (0)
How to titrate betablocker therapy in heart failure patients (2013) (0)
Dependent Mechanism Progenitor Cell Function in Patients With Coronary Artery Disease Through a Short Communication : Asymmetric Dimethylarginine Impairs Angiogenic (2010) (0)
Abstract 14173: Depletion of Neutrophils Ablates Cardiac Ruptures after Treatment with TWEAK (Tumor Necrosis Factor-Like Weak Inducer of Apoptosis) in a Mouse Model of Myocardial Infarction (2012) (0)
[A systemic disease with different etiologies: cardiac insufficiency]. (2015) (0)
[Acute heart failure and cardiogenic shock: pathophysiology, clinical aspects and management strategies]. (2005) (0)
Impact of regional left ventricular function on diagnosis, staging and prognosis in patients with cardiac amyloidosis (2012) (0)
[Multimorbidity - choosing wisely inspite of lacking data]. (2017) (0)
P5450Evening levels and circadian changes of salivary cortisol predict adverse events in heart failure patients with comorbid depression - a MOOD-HF substudy (2019) (0)
Impact of left ventricular ejection fraction phenotypes on healthcare-resource utilization in hospitalized heart failure: A secondary analysis of REPORT-HF. (2023) (0)
P2612Anaemia and renal impairment in heart failure: prevalence and differential prognostic importance according to the AHA ACC heart failure classification (2019) (0)
[Primary diagnosis of heart failure in ambulatory and hospitalized patients]. (2008) (0)
[Guidelines in the German Health Care System]. (2019) (0)
Abstract 19397: Poor Appetite or Overeating Predict Shorter Survival in Chronic Systolic Heart Failure (2012) (0)
P3545Association between diastolic dysfunction and two-year survival in heart failure patients with mid-range or reduced left ventricular ejection fraction (2019) (0)
[Individuality in medicine and science]. (2008) (0)
[Ventricular arrhythmias in chronic disease following myocardial infarct]. (1974) (0)
P2513Health-related quality of life is lower in women than in men amongst patients hospitalized for decompensated systolic heart failure (2017) (0)
[Heart failure with preserved ejection fraction (diastolic heart failure)]. (2019) (0)
[To the speech made by Dr. Annette Schavan, Minister of Education and Research, at the 114th Congress of the German Society of Internal Medicine]. (2008) (0)
155 A method for in vivo 3D assessment of infarct expansion: infarct extent (2005) (0)
Abstract 873: Differential Effects of Long-Acting Nitrates on Endothelial Progenitor Cells are Determined by Reactive Oxygen Species Formation (2006) (0)
Global wasted myocardial is unrelated to conventional markers of systolic and diastolic function in patients with acute heart failure (2021) (0)
Determinants and prognostic implication of improved left ventricular ejection fraction in chronic heart failure patients with reduced ejection fraction (2020) (0)
FatalAspergillus fumigatus septicemia in a patient with an ectopic ACTH-producing neuroendocrine pancreatic tumor (1999) (0)
Abstract 714: Targeting Coagulation Factor XII to Protect from Cardiac Ischemia Reperfusion Injury (2007) (0)
P07—Ventricular Arrhythmias are the Major Cause of Death in Patients With the Classical Phenotype of Fabry Disease (2012) (0)
Th-W52:5 Age-dependent impairment of endothelial progenitor cells is corrected by growth hormone mediated increase of insulin-like growth factor-1 (2006) (0)
Longitudinal base-to-apex strain gradient is a good diagnostic marker for differentiating patients with cardiac amyloidosis from other hypertrophic cardiomyopathies (2012) (0)
107 Development of phenotype and expression of contractile proteins & molecular markers of heart failure over time in beta1‐receptor antibody‐induced immune‐cardiomyopathy (2008) (0)
Effect of Angiotensin-Converting Enzyme Inhibitors on Myocardial Perfusion (1988) (0)
[Treatment after myocardial infarct with ACE inhibitors. Are all problems solved by "mega-studies"?]. (1995) (0)
Abstract 413: Different Effects Of Organic Nitrates On Endothelial Progenitor Cell Mobilisation And Endothelial Function In Patients With Established Coronary Artery Disease (2008) (0)
Poster Session 4: Friday 9 December 2011, 14:00-18:00 * Location: Poster Area (2011) (0)
OBSTRUCTIVE VENTILATORY DISORDER IN HEART FAILURE: NOT ALWAYS COPD! (2010) (0)
Poster session I * Thursday 9 December 2010, 08:30-12:30 (2010) (0)
Abstract 277: Development of Anxiety- and Depression-Like Behavior in Mice After Myocardial Infarction (2012) (0)
In vivo 31 P cardiac nuclear magnetic resonance spectroscopy. Methods and first clinical results (1991) (0)
Humoral control of coronary blood flow (1992) (0)
Coronary effects of neuropeptides in dogs: role of cyclooxygenase products as mediators. (1989) (0)
[Assessment of systolic function in patients with poor echogenicity: echocardiographic methods]. (2015) (0)
Angiotensin Converting Enzyme Inhibitors in Angina and Myocardial Infarction (1993) (0)
Systolic blood pressure and outcome in patients admitted with acute heart failure: a pooled analysis from 4 randomized clinical trials (2021) (0)
[Therapy of chronic left heart failure]. (2007) (0)
Oral Abstract session * The importance of cardiac imaging in systemic diseases: 12/12/2013, 08:30-10:00 * Location: Bursa (2013) (0)
OxLDL induziert über die Regulation der p27 Expression die Proliferation in HUVEC: Rolle von RhoA (2009) (0)
Reply to: Risk assessment of depression by questionnaire for patients with heart failure. (2013) (0)
Substitution of coagulation factor XIII partially restores scar healing after myocardial infarction in factor XIII knockout mice (2003) (0)
4935Biomarker profile of patients with recovery of left ventricular systolic function following acute cardiac decompensation (2018) (0)
Differential effects of neuromelanin and synthetic dopamine melanin on cell lines Inaugural – (2005) (0)
584 Diminished endothelial progenitor cell mobilisation from bone marrow after acute large myocardial infarction: Differential stimulation by ACE inhibition or statin treatment (2005) (0)
Abstract 15407: Pentaerythrityl Tetranitrate Treatment Improves Left Ventricular Function and Reduces Mitochondrial Superoxide Anion-Production in Rats With Ischemic Heart Failure (2010) (0)
Therapeutic Monitoring of Direct Oral Anticoagulants—Back to the Future? (2020) (0)
Medicine in free market economies. (2012) (0)
[Indications for ACE inhibitors in the postinfarct period]. (1994) (0)
In Vivo Assessment of Rat Hearts with and without Myocardial Infarction by Cine NMR - Comparison of the NMR Method to Invasive Techniques and Application to Intervention Studies (2001) (0)
European Perspectives in Cardiology European Perspectives in Cardiology Limitation of Experimental Infarct Size by Angiotensin-Converting Enzyme Inhibitor in 1982 “Led to Research Into Early Interventions to Prevent Heart Failure After Myocardial Infarction” (2010) (0)
We-W34:5 Fractalkine induces vascular dysfunction and reduces nitric oxide bioavailability by increased generation of superoxide anions (2006) (0)
ACE-inhibitor (Quinapril) treatment early after large myocardial infarction improves cardiac function and remodeling in rats (1992) (0)
Pathophysiology of LV hypertrophy in hypertension (2006) (0)
[From cardiovascular risk to chronic heart failure]. (2003) (0)
P1100Efficacy of enzyme replacement therapy in Fabry disease with advanced organ involvement (2017) (0)
P803 Myocardial work in acutely decompensated heart failure patients differs between HFrEF and HFpEF (2020) (0)
Septal mitral annular systolic excursion but not global longitudinal strain predicts outcome in non-ischemic heart failure patients with reduced ejection fraction and mild diastolic dysfunction (2020) (0)
P579Incremental prognostic value of cardiac biomarkers in diagnostically naive patients with suspected heart failure - comparison with a clinical base model (2017) (0)
Disease management for nondepressed heart failure patients only fact or artifact? (2010) (0)
[How to join interdisciplinary research and health care]. (2013) (0)
Abstract 336: Cardiomyocyte-specific Deletion of the Mineralocorticoid Receptor attenuates Cardiac Dilatation and Dysfunction after Myocardial Infarction (2008) (0)
[Notifications of the German Society for Internal Medicine]. (2008) (0)
288 Prevalence and determinants of depression in chronic systolic heart failure (2007) (0)
Abstract 12608: Detrimental Role of Complement After Myocardial Infarction (2010) (0)
Hemodynamic Response to Anqiotensin II Receptor B!ockade With Losortan In Heart Failure (2013) (0)
PREVALENCE AND PROGNOSTIC IMPACT OF ANEMIA AND RENAL INSUFFICIENCY: RELATION TO HEART FAILURE SEVERITY (2011) (0)
P1098Treatment of Fabry disease with a new oral drug: Initial real-world single-center experience (2017) (0)
P1432 Heart failure subgroups according to left ventricular ejection fraction A latent class analysis (2020) (0)
Abstract 117: TWEAK (Tumor Necrosis Factor-Like Weak Inducer of Apoptosis) Impedes Healing After Myocardial Infarction in Mice (2012) (0)
Abstract 12010: Role of T-cells in Myocardial Ischemia-Reperfusion Injury (2012) (0)
Sequential noninvasive measurement of relative blood volumein surviving myocardium of infarcted rat hearts: A NMR-relaxometry study in intact animals (1996) (0)
Clinical studies with vasodilators in heart failure (1992) (0)
[Angiotensin I converting enzyme and carboxypeptidase B-like enzymes in sarcoidosis and other lung diseases]. (1983) (0)
Abstract 18390: Influence of Fluid Retention on Pulmonary Function Testing in Heart Failure. (2010) (0)
Regional Myocardial Deformation in Adult Patients with Isolated Left Ventricular Non-compaction Cardiomyopathy (2011) (0)
P6191Patients not consenting in registry participation- another black box in acute heart failure registries. Results from AHF Registry (2017) (0)
P958ICD generator replacement in patients not receiving appropriate therapy during the initial battery lifespan (2017) (0)
P10—Comprehensive Assessment of Long-Term Enzyme Replacement Therapy in Fabry Disease: The 5-Year Data (2012) (0)
P3753Portable echocardiography in patients with suspected heart failure in primary care. Prevalence and prognostic significance of abnormal findings (2018) (0)
Fusion imaging in chronic coronary artery stenosis of the rat by phosphorus spectroscopy and magnetic resonance coronary angiography (2003) (0)
Differential mortality risk prediction by aldosterone and cortisol in systolic heart failure with versus without mineralocorticoid receptor blockade (2013) (0)
The long-term effect of enzyme replacement therapy on regression of left ventricular hypertrophy in patients with Fabry cardiomyopathy. Impact of baseline findings (2007) (0)
[Heart failure]. (2011) (0)
Abstract 13735: CD4+ T-lymphocytes Modulate Wound Healing After Experimental Myocardial Infarction In Mice (2010) (0)
Morphometric analysis of rat hearts (therapy-study). (2015) (0)
825 Regression of left ventricular hypertrophy in patients with fabry cardiomyopathy during long term enzyme replacement therapy - the impact of the baseline conditions (2006) (0)
Transforming growth factor-beta2 and thoracic aortic aneurysm (2013) (0)
Small Interference RNA-Mediated Knockdown of eNOS in EPC (2007) (0)
Angiotensin converting enzyme inhibitors in angina and myocardial infarction. What role will they play in the 1990s? (1993) (0)
Methodology: perfusion and diffusion (2007) (0)
Abstract 13806: Multidrug Resistance Associated Protein-1 (MRP-1) Deficiency Prevents Endothelial Dysfunction In Diabetes (2010) (0)
Abstract 3307: Tissue Specific Effects of the Transcription Factor Nuclear Factor Kappa B on Myocardial Ischemic Injury (2009) (0)
Function and Outcome Low-Gradient Aortic Valve Stenosis: Myocardial Fibrosis and Its Influence on (2011) (0)
Saturday, 17 July 2010 (2010) (0)
Abstract 1262: Selective Activation of Estrogen Receptor-{alpha} or Estrogen Receptor-{beta} Attenuates Hypertension and Cardiac Hypertrophy in Aldosterone Salt Treated Rats (2006) (0)
1001-37 Strain rate imaging differentiates myocardial hypertrophy induced either by arterial hypertension or aortic stenosis (2004) (0)
[Medical specialist training internal medicine : Case-related learning using the new Model-Speciality-Training-Regulations]. (2021) (0)
[Arrhythmias following acute myocardial infarct. Comparison of the ambulatory and stationary phase]. (1976) (0)
European (jß Volume 12 Supplement D Pages 1-205 Pericardioscopy—a New Diagnostic Tool in Inflammatory Diseases of the Pericardium the Role of Pericardiectomy in Pericardial Disorders the Value of Endomyocardial Biopsies in Myocarditis and Dilated Cardiomyopathy Endomyocardial Biopsy Findings in Case (0)
Abstract 11309: Significance of Blood Pressure Drops in Patients Hospitalized for Acute Heart Failure: A Patient-Level Analysis of 4 Randomized Placebo-Controlled Serelaxin Trials (2021) (0)
[Diagnosis and therapy of chronic heart failure]. (2004) (0)
31P-NMR SPECTROSCOPY OF BLOOD IN VOLUNTEERS AND PATIENTS WITH CONGESTIVE-HEART-FAILURE (1992) (0)
P2619Impact of myocardial fibrosis on 10-year-outcome in patients undergoing aortic valve replacement (2017) (0)
P1751 Right ventricular dysfunction in heart failure patients with reduced ejection fraction with and without chronic respiratory diseases: A treacherous combination for the ominous outcome? (2020) (0)
674 Prognostic value of androgens in male patients with chronic heart failure (2007) (0)
Magnetic Resonance Fusion Imaging of Chronic Myocardial Ischemia (2003) (0)
Improved Cardiac Glucose Uptake : A Potential Mechanism for Estrogens to Prevent the Development of Cardiac Hypertrophy (2009) (0)
Angiotensin receptor blockers : baseline therapy in hypertension ? (2009) (0)
[Imaging in internal medicine]. (2008) (0)
The Year in Cardiology The Year in Cardiology 2013: heart failure Acute heart failure, a dawn of hope for therapy? (2014) (0)
[Effect of the cardiac renin-angiotensin system on hypertrophy]. (1996) (0)
Poster session Thursday 12 December - PM: 12/12/2013, 14:00-18:00 * Location: Poster area (2013) (0)
[Arrhythmias during remodeling after myocardial infarction]. (2002) (0)
Abstract: 563 ROLE OF NNOS IN ATHEROSCLEROSIS (2009) (0)
[Cardioverter-defibrillator (ICD) and resynchronization in every patient with cardiac failure--Against]. (2006) (0)
Abstract 15058: Disruption of Extracellular Cytotoxic Chromatin by Acute DNase1 Administration Improves Left Ventricular Remodeling after Myocardial Infarction (2014) (0)
[Prevention with angiotensin-converting enzyme (ACE) inhibitors]. (1992) (0)
New aspects of drug therapy in ischaemic heart disease. Introduction. (1990) (0)
161 Impact of right ventricular dysfunction on outcome in heart failure patients with mid-range ejection fraction with and without chronic respiratory diseases (2020) (0)
Abstract 5390: The Endothelial Nitric Oxide Synthase Enhancer AVE9488 Increases Circulating Endothelial Progenitor Cells and Prevents Heart Failure Early after Myocardial Infarction (2008) (0)
525 Clinical profile and quality of care in a regional registry of consecutive heart failure patients in Germany (2004) (0)
Fibrosis in hypertrophic myocardium can be detected by a typical double peak sign extracted from deformation curves (2007) (0)
Absence of NF- (cid:1) B subunit p50 improves heart failure after myocardial infarction (2006) (0)
[Internal Medicine and Infectious Diseases]. (2020) (0)
990-51 Mechanisms and Predictors of Late Death in Asymptomatic Patients After Myocardial Infarction. A Prospective Study on Remodeling (1995) (0)
Abstract 4912: Multidrug Resistance Associated Protein-1 (MRP-1) Regulates Endothelial Cell Apoptosis (2009) (0)
Time-course of right ventricular remodeling after experimental myocardial infarction in rats (1996) (0)
P3551Right ventricular dysfunction in heart failure patients with reduced ejection fraction with and without chronic respiratory diseases: A treacherous combination for the ominous outcome? (2019) (0)
CardioPulse: the strengths and limitations of the German health-care system. (2013) (0)
Pathogenic relevance of autoantibodies in dilated cardiomyopathy (2010) (0)
Inhibition of cardiac hypertrophy and improved hemodynamics in estrogen deficient SHR via selective activation of ER-alpha (2004) (0)
Abstract 1758: Attenuation of Angiotensin II induced Hypertension, Vascular Dysfunction and Cardiomyocyte Hypertrophy by Overexpression of Thioredoxin-2 (2008) (0)
Oxidative Stress Early After Myocardial Infarction Mineralocorticoid Receptor Blockade Improves Vasomotor Dysfunction and Vascular (2007) (0)
[Possibilities of ACE inhibitor therapy in acute myocardial ischemia]. (1991) (0)
2455Predictive value of diastolic dysfunction severity on long-term survival in heart failure patients with mid-range or reduced left ventricular ejection fraction (2018) (0)
[The Fabry's Disease Cardiomyopathy as Differential Diagnosis of Acute Coronary Syndrome]. (2017) (0)
P4513Impact of right ventricular dysfunction on outcome in heart failure patients with mid-range ejection fraction with and without chronic respiratory diseases (2019) (0)
Impact of right and left ventricular dysfunction on long-term outcome of moderate to severe secondary mitral regurgitation patients without surgical/interventional treatment (2020) (0)
Indication of ACE-inhibitors post-myocardial infarction (1994) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With George Ertl?

George Ertl is affiliated with the following schools: